Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
設定
言語
日本
通貨
USD
テーマ
CSL Limited CSL Limited

CSL Limited

CSL
株式のランク #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
株価
$99.32
時価総額
$48.20B
変化（1日）
0.98%
変化（1年）
-32.14%
国
AU
取引 CSL Limited (CSL)

カテゴリー

Healthcare
CSL Limited（CSL）の営業利益率
April 2026 時点の営業利益率 TTM: 25.72%
CSL Limited の最新の財務報告と株価によると、現在の営業利益率（TTM）は 25.72% です。2024 年末時点では 18.82% でした。
CSL Limited の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
年 営業利益率 変化
2026 (TTM) 25.72% 34.10%
2025 19.18% 1.91%
2024 18.82% 17.92%
2023 15.96% -27.68%
2022 22.07% -11.97%
2021 25.07% 4.98%
2020 23.88% -17.28%
2019 28.87% 22.59%
2018 23.55% 27.09%
2017 18.53% 11.02%
2016 16.69% -35.98%
2015 26.07% 2.64%
2014 25.40% 10.82%
2013 22.92% 13.69%
2012 20.16% -7.48%
2011 21.79% -9.25%
2010 24.01% 30.70%
2009 18.37% 6.55%
2008 17.24% 0.23%
2007 17.20% 1,146.38%
2006 1.38% -84.17%
2005 8.72% 448.43%
2004 1.59% -63.95%
2003 4.41% -49.60%
2002 8.75% -193.38%
2001 -9.37% 0.00%
2000 0.00% 0.00%
同業他社の営業利益率
企業 営業利益率 営業利益率の差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
41.30% -98.39%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
35.45% -98.62%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.95% -99.03%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -99.02%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -99.00%
NL
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。